Benzinga | Jun 23, 2021 02:00PM EDT

JMP Securities Maintains Market Outperform on Evelo Biosciences, Raises Price Target to $38

JMP Securities analyst Gobind Singh maintains Evelo Biosciences (NASDAQ:EVLO) with a Market Outperform and raises the price target from $36 to $38.